BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Memory Pharmaceuticals Corp. 

100 Philips Parkway

Montvale  New Jersey  07645  U.S.A.
Phone: 201-802-7100 Fax: 201-802-7190


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Roche (RHHBY) (JOBS) Purchases Shares in Tender Offer For Memory Pharmaceuticals (MEMY) 1/2/2009 6:31:58 AM
Memory Pharmaceuticals (MEMY) Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia 12/29/2008 10:22:53 AM
Memory Pharmaceuticals (MEMY) Reports Phase 1 Data for R4996/MEM 63908 12/19/2008 10:13:10 AM
Memory Pharmaceuticals (MEMY) Initiates Phase 2a Trial for MEM 1414 in Asthma 12/19/2008 9:52:53 AM
Memory Pharmaceuticals (MEMY) Regains Compliance with NASDAQ Market Capitalization Requirement 12/16/2008 10:17:44 AM
Roche (RHHBY) (JOBS) Signs Definitive Agreement to Acquire Memory Pharmaceuticals (MEMY) for Approximately $50 Million 11/25/2008 6:25:33 AM
Memory Pharmaceuticals (MEMY) Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 11/19/2008 8:07:29 AM
Memory Pharmaceuticals (MEMY) Reports Third Quarter 2008 Financial Results 11/13/2008 9:18:34 AM
Memory Pharmaceuticals (MEMY) Announces Six Abstracts Accepted for Presentation at Society For Neuroscience Meeting 11/10/2008 8:42:17 AM
Memory Pharmaceuticals (MEMY) to Present at the Rodman & Renshaw Annual Global Investment Conference 11/7/2008 8:51:15 AM
12345678910...